Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-06-03 | 2021-07-15 | 140387 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-07-29 | 2021-09-09 | 143250 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-08-27 | 2021-11-18 | 144707 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-09-23 | 2021-10-28 | 146095 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-10-21 | 2021-11-18 | 147696 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-01-20 | 2022-03-24 | 153147 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-01-27 | 2022-03-18 | 153730 |
TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2022-02-10 | 2022-04-01 | 154717 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-02-17 | 2022-04-21 | 155149 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-04-21 | 2022-06-17 | 159192 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-03 | 2022-12-08 | 161928 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-09 | 2023-01-18 | 162271 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-08-18 | 2023-07-21 | 167209 |
TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2022-09-22 | 2022-12-02 | 169961 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-12-01 | 2022-12-15 | 176800 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2023-06-19 | 2023-07-05 | 195472 |
TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2023-06-26 | 2023-07-06 | 196403 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-02-29 | 2024-05-03 | 220986 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-04-11 | 2024-04-18 | 224886 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2017-09-21 | 2017-11-07 | 22948 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |